Literature DB >> 11588630

Applicability of the CERAD neuropsychological battery to Brazilian elderly.

P H Bertolucci1, I H Okamoto, S M Brucki, M O Siviero, J Toniolo Neto, L R Ramos.   

Abstract

There is a limited choice of psychometric tests for Portuguese speaking people which have been evaluated in well defined groups. A Portuguese version of CERAD neuropsychological battery was applied to a control group of healthy elderly (CG) (mean age 75.1 years/ education 7.9 years), 31 Alzheimer disease (AD) patients classified by clinical dementia rating (CDR) as CDR1 (71.4/ 9.0) and 12 AD patients CDR 2 (74.1/ 9.3). Cut-off points were: verbal fluency-11; modified Boston naming-12; Mini-mental State Examination (MMSE) -26; word list memory-13; constructional praxis-9; word recall-3, word recognition-7; praxis recall-4. There was a significant difference between CG and AD-CDR1 (p<0.0001) for all tests. There was a less significant difference for constructional praxis and no difference for Boston naming. Comparison between AD-CDR1 and AD-CDR2 showed difference only for MMSE, verbal fluency, and Boston naming. The performance of CG was similar to that of a US control sample with comparable education level. These results indicate that this adaptation may be useful for the diagnosis of mild dementia but further studies are needed to define cut-offs for illiterates/low education people.

Entities:  

Mesh:

Year:  2001        PMID: 11588630     DOI: 10.1590/s0004-282x2001000400009

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  66 in total

1.  The neuropsychological performance of nondemented Puerto Rican nonagenarians.

Authors:  José R Carrión-Baralt; Josefina Meléndez-Cabrero; Michal Schnaider Beeri; Mary Sano; Jeremy M Silverman
Journal:  Dement Geriatr Cogn Disord       Date:  2009-03-17       Impact factor: 2.959

2.  Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial.

Authors:  Bárbara Rita Cardoso; Daniel Apolinário; Verônica da Silva Bandeira; Alexandre Leopold Busse; Regina Miksian Magaldi; Wilson Jacob-Filho; Silvia Maria Franciscato Cozzolino
Journal:  Eur J Nutr       Date:  2015-01-08       Impact factor: 5.614

3.  APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.

Authors:  Elizabeth Suchi Chen; Tatiane Katsue Furuya; Diego Robles Mazzotti; Vanessa Kiyomi Ota; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Lipids       Date:  2010-05-18       Impact factor: 1.880

4.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

5.  Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

Authors:  M S Beeri; J Schmeidler; M Sano; J Wang; R Lally; H Grossman; J M Silverman
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

6.  Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.

Authors:  Elizabeth Suchi Chen; Diego Robles Mazzotti; Tatiane Katsue Furuya; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

7.  Diagnostic utility of the NAB List Learning test in Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Brandon E Gavett; Sabrina J Poon; Al Ozonoff; Angela L Jefferson; Anil K Nair; Robert C Green; Robert A Stern
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

8.  Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Authors:  Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman
Journal:  Alzheimers Dement       Date:  2008-03       Impact factor: 21.566

9.  CSF Aβ1-42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer's Disease Dementia.

Authors:  Liara Rizzi; Luciane Missiaggia; Matheus Roriz-Cruz
Journal:  Neuromolecular Med       Date:  2018-10-10       Impact factor: 3.843

10.  Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey.

Authors:  Ana Luisa Sosa; Emiliano Albanese; Martin Prince; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Juan Llibre de Rodriguez; Aquiles Salas; Fang Yang; Ciro Gaona; At Joteeshwaran; Guillermina Rodriguez; Gabriela Rojas de la Torre; Joseph D Williams; Robert Stewart
Journal:  BMC Neurol       Date:  2009-08-26       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.